| Literature DB >> 28814876 |
Muhammet Kazim Erol1, Ayse Balkarli2, Ozgur Yucel1, Yusuf Akar3, Berna Dogan1, Elcin Suren1.
Abstract
PURPOSE: This study aimed to evaluate mean platelet volume (MPV) and neutrophil/lymphocyte ratio (NLR) values and their relationship with clinical findings in patients with central serous chorioretinopathy (CSCR).Entities:
Keywords: central serous chorioretinopathy; mean platelet volume; neutrophil/lymphocyte ratio
Year: 2017 PMID: 28814876 PMCID: PMC5545637 DOI: 10.2147/TCRM.S138581
Source DB: PubMed Journal: Ther Clin Risk Manag ISSN: 1176-6336 Impact factor: 2.423
Baseline characteristics in CSCR groups
| Baseline characteristics | Group 1 | Group 2 | |
|---|---|---|---|
| BMI (kg/m2) | 25.94±3.09 | 26.95±3.87 | 0.181 |
| Length of education (years) | 8 (5–16) | 8 (5–16) | 0.773 |
| Disease duration (months) | 18 (5–72) | ||
| Choroidal thickness (µm) | 397.8±119.34 | 394.95±94.52 | 0.908 |
| Marital status | |||
| Married, n (%) | 34 (79.1) | 38 (86.4) | 0.368 |
| Single, n (%) | 9 (20.9) | 6 (13.6) | |
| Presence of work stress, n (%) | 23 (53.5) | 21 (47.7) | 0.591 |
| Presence of familial stress, n (%) | 16 (37.2) | 18 (40.9) | 0.724 |
Notes:
Independent samples t-test with mean ± SD.
Mann–Whitney U-test with median (min–max).
Pearson chi-square test with n (%). Group 1: Acute CSCR; Group 2: Chronic CSCR.
Abbreviations: BMI, body mass index; CSCR, central serous chorioretinopathy.
Baseline characteristics and parameters evaluated in all study groups
| Group 1 | Group 2 | Group 3 | ||
|---|---|---|---|---|
| Age (years) | 47.33±10.72 | 48.86±11.41 | 48.21±10.89 | 0.804 |
| Male, n (%) | 32 (74.4) | 31 (70.5) | 250 (78.1) | 0.485 |
| MPV (f/L) | 8.58±0.91 | 9.53±1.17 | 8.56±0.92 | <0.001 |
| CRP (mg/L) | 4 (3–5.7) | 3.5 (2–5) | 3.8 (2–5.7) | 0.001 |
| ESR (mm/h) | 10.93±4.21 | 10.41±4.51 | 10.83±4.38 | 0.817 |
| NLR | 2.32 (1.13–6.27) | 1.6 (0.57–3.5) | 1.72 (0.78–11.25) | <0.001 |
Notes:
Analysis of variance with mean ± SD.
Pearson chi-square test with n (%).
Kruskal–Wallis with median (min–max).
Indicate inter-group differences. Group 1: Acute CSCR; Group 2: Chronic CSCR; Group 3: Control.
Abbreviations: CRP, C-reactive protein (normal range: 0–5 mg/L); CSCR, central serous chorioretinopathy; ESR, erythrocyte sedimentation rate (normal range: 0–20 mm/h); MPV, mean platelet volume (normal range: 7.4–40.4 f/L); NLR, neutrophil/lymphocyte ratio.
Logistic regression analysis of independent risk factors for identification of chronic disease
| Variables | CSCR Group 3
| Group 2 Group 1
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Wald | OR | 95% CI for OR
| Wald | OR | 95% CI for OR
| |||||
| Lower | Upper | Lower | Upper | |||||||
| MPV | 16.602 | <0.001 | 1.657 | 1.300 | 2.112 | 6.221 | 0.013 | 1.999 | 1.160 | 3.445 |
| CRP | 0.152 | 0.696 | 1.069 | 0.763 | 1.498 | 6.600 | 0.010 | 0.326 | 0.139 | 0.767 |
| NLR | 1.880 | 0.170 | 1.148 | 0.942 | 1.399 | 5.67 | 0.017 | 0.295 | 0.108 | 0.806 |
Notes: Group 1: Acute CSCR; Group 2: Chronic CSCR; Group 3: Control.
Abbreviations: CRP, C-reactive protein; CSCR, central serous chorioretinopathy; MPV, mean platelet volume; NLR, neutrophil/lymphocyte ratio; OR, odds ratio.
Results of ROC analyses of NLR and MPV in acute and chronic CSCR groups
| Groups 1 and 2
| ||||
|---|---|---|---|---|
| AUC | Cutoff | Sensitivity | Specificity | |
| MPV | 0.744 | 8.95 | 0.705 | 0.721 |
| NLR | 0.799 | 1.93 | 0.750 | 0.744 |
Notes: Group 1: Acute CSCR; Group 2: Chronic CSCR.
Abbreviations: AUC, area under curve; CSCR, central serous chorioretinopathy; MPV, mean platelet volume; NLR, neutrophil/lymphocyte ratio; ROC, receiver operating characteristic.